Lilly Xigris Indication For Low-Risk Sepsis Could Require Large Study
Lilly's Xigris efficacy assessment in low-risk sepsis patients would require a large trial population, FDA's Anti-Infective Drugs Advisory Committee suggested Oct. 16.
Lilly's Xigris efficacy assessment in low-risk sepsis patients would require a large trial population, FDA's Anti-Infective Drugs Advisory Committee suggested Oct. 16.